drugset / Trial / NCT07564726

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

NCT07564726

Phase 3 Completed 163 enrolled Celltrion Pharm, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to test whether one pill that combines ezetimibe, rosuvastatin, and amlodipine can safely lower cholesterol and blood pressure in Korean adults with high blood pressure and high cholesterol.

Timeline

Start
2022-08-05
Primary completion
2024-02-13
Completion
2024-02-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Ezetimibe Unknown 10 mg Oral
Subject Rosuvastatin Small molecule 20 mg Oral